Skip to main content
AXSM logo

AXSM · Axsome Therapeutics, Inc. · Analyst Estimates

Track AXSM — free
$184.39 -1.75 (-0.94%) At close · Sep 30
Market Cap
$9.75B
Shares
52.38M
Volume · Sep 30 1.03M Avg daily vol (3M) 703.8K

Analyst Estimates

Compare analyst forecasts for Axsome Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 13:38 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.79
-2.6886
-1.6
—
-2.63666
-1.72696
-2.63666
-1.75106
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
6
7
2
4
Revenue
USD
Publication date not stated
874564000
963508800
1029400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.37
4.67948
7.83
—
5.03398
5.84769
5.03398
5.89745
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
6
6
3
5
Revenue
USD
Publication date not stated
1339000000
1547699730
1745700000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.0
-0.47923
-0.03
—
-0.4628
-0.28444
-0.4628
-0.33444
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
6
6
2
3
Revenue
USD
Publication date not stated
227865000
257515120
281900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
20
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.55
0.03602
0.68
—
0.07294
0.34889
0.07294
0.29444
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
5
6
3
3
Revenue
USD
Publication date not stated
237121000
296332880
338000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —
Key facts CIK 1579428 CUSIP 05464T104 13F (30d) 9 filings 9 filers Visit website Investor relations